Skip to main content Accessibility help
×
Home

Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia

  • S. M. Eack (a1) (a2), M. F. Pogue-Geile (a3), D. P. Greenwald (a2), S. S. Hogarty (a2) and M. S. Keshavan (a2) (a4)...

Abstract

Background

Cognitive rehabilitation has emerged as an effective treatment for addressing cognitive impairments and functional disability in schizophrenia; however, the degree to which changes in various social and non-social cognitive processes translate into improved functioning during treatment remains unclear. This research sought to identify the neurocognitive and social-cognitive mechanisms of functional improvement during a 2-year trial of cognitive enhancement therapy (CET) for early-course schizophrenia.

Method

Patients in the early course of schizophrenia were randomly assigned to CET (n=31) or an enriched supportive therapy control (n=27) and treated for up to 2 years. A comprehensive neurocognitive assessment battery and the Mayer–Salovey–Caruso Emotional Intelligence Test (MSCEIT) were completed annually, along with measures of functioning. Mediator analyses using mixed-effects growth models were conducted to examine the effects of neurocognitive and social-cognitive improvement on functional change.

Results

Improvements over 2 years in neurocognition and the emotion management branch of the MSCEIT were found to be significantly related to improved functional outcome in early-course schizophrenia patients. Neurocognitive improvement, primarily in executive functioning, and social-cognitive change in emotion management also mediated the robust effects of CET on functioning.

Conclusions

Improvements in neurocognition and social cognition that result from cognitive rehabilitation are both significant mediators of functional improvement in early-course schizophrenia. Cognitive rehabilitation programs for schizophrenia may need to target deficits in both social and non-social cognition to achieve an optimal functional response.

Copyright

Corresponding author

*Address for correspondence: S. M. Eack, Ph.D., University of Pittsburgh School of Social Work, 2117 Cathedral of Learning, Pittsburgh, PA 15260, USA. (Email: sme12@pitt.edu)

References

Hide All
Baron, RM, Kenny, DA (1986). The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 51, 11731182.
Brekke, JS, Hoe, M, Green, MF (2009). Neurocognitive change, functional change and service intensity during community-based psychosocial rehabilitation for schizophrenia. Psychological Medicine 39, 16371647.
Brekke, JS, Hoe, M, Long, J, Green, MF (2007). How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophrenia Bulletin 33, 12471256.
Buchanan, RW, Heinrichs, DW (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 27, 335350.
Campbell, DT, Stanley, JC (1963). Experimental and Quasi-Experimental Designs for Research. Houghton Mifflin: Boston, MA.
Couture, SM, Penn, DL, Roberts, DL (2006). The functional significance of social cognition in schizophrenia: a review. Schizophrenia Bulletin 32 (Suppl. 1), S44S63.
Delis, DC, Kramer, JH, Kaplan, E, Ober, BA (1987). California Verbal Learning Test Manual. Psychological Corp.: San Antonio, TX.
Dempster, AP, Laird, NM, Rubin, DB (1977). Maximum likelihood from incomplete data using the EM algorithm. Journal of the Royal Statistical Society. Series B (Methodological) 39, 138.
Department of Health and Human Services (1986). Disability Evaluation Under Social Security. Department of Health and Human Services: Washington, DC.
Eack, SM, Greeno, CG, Pogue-Geile, MF, Newhill, CE, Hogarty, GE, Keshavan, MS (2010). Assessing social-cognitive deficits in schizophrenia with the Mayer–Salovey–Caruso Emotional Intelligence Test. Schizophrenia Bulletin 36, 370380.
Eack, SM, Greenwald, DP, Hogarty, SS, Cooley, SJ, DiBarry, AL, Montrose, DM, Keshavan, MS (2009). Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatric Services 60, 14681476.
Eack, SM, Hogarty, GE, Greenwald, DP, Hogarty, SS, Keshavan, MS (2007). Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophrenia Research 89, 308311.
Eack, SM, Hogarty, GE, Greenwald, DP, Hogarty, SS, Keshavan, MS (in press). Effects of cognitive enhancement therapy on employment outcomes in early schizophrenia: results from a two-year randomized trial. Research on Social Work Practice.
Endicott, J, Spitzer, RL, Fleiss, JL, Cohen, J (1976). The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766771.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. Biometrics Research, New York State Psychiatric Institute: New York.
Green, MF, Kern, RS, Braff, DL, Mintz, J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuff? Schizophrenia Bulletin 26, 119136.
Green, MF, Nuechterlein, KH (1999). Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin 25, 309319.
Green, MF, Nuechterlein, KH, Gold, JM, Barch, DM, Cohen, J, Essock, S, Fenton, WS, Frese, F, Goldberg, TE, Heaton, RK, Keefe, RS, Kern, RS, Kraemer, H, Stover, E, Weinberger, DR, Zalcman, S, Marder, SR (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry 56, 301307.
Heaton, RK, Chelune, GJ, Talley, JL, Kay, GG, Curtiss, G (1993). Wisconsin Card Sorting Test Manual: Revised and Expanded. Psychological Assessment Resources Inc.: Odessa, FL.
Heinrichs, RW, Zakzanis, KK (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426445.
Hogarty, GE (2002). Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment. Guilford: New York.
Hogarty, GE, Flesher, S (1992). Cognitive remediation in schizophrenia: proceed … with caution! Schizophrenia Bulletin 18, 5157.
Hogarty, GE, Flesher, S, Ulrich, R, Carter, M, Greenwald, D, Pogue-Geile, M, Kechavan, M, Cooley, S, DiBarry, AL, Garrett, A, Parepally, H, Zoretich, R (2004). Cognitive enhancement therapy for schizophrenia. Effects of a 2-year randomized trial on cognition and behavior. Archives of General Psychiatry 61, 866876.
Hogarty, GE, Goldberg, SC, Schooler, NR, the Collaborative Study Group (1974). Drug and sociotherapy in the aftercare of schizophrenic patients: III. Adjustment of nonrelapsed patients. Archives of General Psychiatry 31, 609618.
Hogarty, GE, Greenwald, DP (2006). Cognitive enhancement therapy (http://www.cognitiveenhancementtherapy.com). Accessed 1 September 2010.
Hogarty, GE, Greenwald, DP, Eack, SM (2006). Durability and mechanism of effects of cognitive enhancement therapy. Psychiatric Services 57, 17511757.
Keefe, RSE, Bilder, RM, Davis, SM, Harvey, PD, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Capuano, G, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Davis, CE, Hsiao, JK, Lieberman, JA; CATIE Investigators; Neurocognitive Working Group (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry 64, 633647.
Kraemer, HC, Wilson, G, Fairburn, CG, Agras, W (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59, 877884.
MacKinnon, DP, Lockwood, CM, Hoffman, JM, West, SG, Sheets, V (2002). A comparison of methods to test mediation and other intervening variable effects. Psychological Methods 7, 83–104.
Mayer, JD, Salovey, P, Caruso, DR, Sitarenios, G (2003). Measuring emotional intelligence with the MSCEIT V2.0. Emotion 3, 97–105.
McGurk, SR, Twamley, EW, Sitzer, DI, McHugo, GJ, Mueser, KT (2007). A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry 164, 17911802.
Nuechterlein, KH, Green, MF, Kern, RS, Baade, LE, Barch, DM, Cohen, JD, Essock, S, Fenton, WS, Frese, FJ 3rd, Gold, JM, Goldberg, T, Heaton, RK, Keefe, RS, Kraemer, H, Mesholam-Gately, R, Seidman, LJ, Stover, E, Weinberger, DR, Young, AS, Zalcman, S, Marder, SR (2008). The MATRICS Consensus Cognitive Battery, Part 1: test selection, reliability, and validity. American Journal of Psychiatry 165, 203213.
Penn, DL, Corrigan, PW, Bentall, RP, Racenstein, J, Newman, L (1997). Social cognition in schizophrenia. Psychological Bulletin 121, 114132.
Reeder, C, Newton, E, Frangou, S, Wykes, T (2004). Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophrenia Bulletin 30, 87–100.
Reeder, C, Smedley, N, Butt, K, Bogner, D, Wykes, T (2006). Cognitive predictors of social functioning improvements following cognitive remediation for schizophrenia. Schizophrenia Bulletin 32 (Suppl. 1), S123S131.
Reitan, RM, Waltson, D (1985). The Halstead-Reitan Neuropsychological Test Battery. Neuropsychology Press: Tucson, AZ.
Salovey, P, Mayer, JD (1990). Emotional intelligence. Imagination, Cognition, and Personality 9, 185221.
Schooler, N, Weissman, M, Hogarty, G (1979). Social adjustment scale for schizophrenics. In Resource Material for Community Mental Health Program Evaluators (ed. Hargreaves, W. A., Attkisson, C. C. and Sorenson, J.), pp. 290303. DHHS publication no. (ADM) 79328. United States Department of Health, Education, and Welfare; Rockville, MD.
Sergi, MJ, Green, MF, Widmark, C, Reist, C, Erhart, S, Braff, DL, Kee, KS, Marder, SR, Mintz, J (2007). Cognition and neurocognition: effects of Risperidone, Olanzapine, and Haloperidol. American Journal of Psychiatry 164, 15851592.
Sergi, MJ, Rassovsky, Y, Nuechterlein, KH, Green, MF (2006). Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. American Journal of Psychiatry 163, 448454.
Singer, JD, Willet, JB (2003). Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford University Press: New York.
Wechsler, D (1981). Wechsler Adult Intelligence Scale–Revised. Psychological Corp.: New York.
Wechsler, D (1987). Manual for the Wechsler Memory Scale–Revised. Psychological Corp.: San Antonio, TX.
Wykes, T, Newton, E, Landau, S, Rice, C, Thompson, N, Frangou, S (2007). Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research 94, 221230.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed